- Home
- YORW vs BCYC Comparison
YORW vs BCYC Comparison
Compare YORW & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- BCYC
- Stock Information
- Founded
- YORW 1816
- BCYC 2009
- Country
- YORW United States
- BCYC United Kingdom
- Employees
- YORW N/A
- BCYC N/A
- Industry
- YORW Water Supply
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- YORW Utilities
- BCYC Health Care
- Exchange
- YORW Nasdaq
- BCYC Nasdaq
- Market Cap
- YORW 472.3M
- BCYC 566.5M
- IPO Year
- YORW N/A
- BCYC 2019
- Fundamental
- Price
- YORW $31.20
- BCYC $8.63
- Analyst Decision
- YORW
- BCYC Buy
- Analyst Count
- YORW 0
- BCYC 11
- Target Price
- YORW N/A
- BCYC $25.00
- AVG Volume (30 Days)
- YORW 96.5K
- BCYC 301.6K
- Earning Date
- YORW 08-01-2025
- BCYC 08-05-2025
- Dividend Yield
- YORW 2.79%
- BCYC N/A
- EPS Growth
- YORW N/A
- BCYC N/A
- EPS
- YORW 1.37
- BCYC N/A
- Revenue
- YORW $75,787,000.00
- BCYC $25,722,000.00
- Revenue This Year
- YORW $7.50
- BCYC $7.35
- Revenue Next Year
- YORW $6.33
- BCYC N/A
- P/E Ratio
- YORW $22.95
- BCYC N/A
- Revenue Growth
- YORW 3.45
- BCYC N/A
- 52 Week Low
- YORW $29.86
- BCYC $6.10
- 52 Week High
- YORW $41.96
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- YORW 46.38
- BCYC 56.38
- Support Level
- YORW $31.02
- BCYC $7.66
- Resistance Level
- YORW $32.45
- BCYC $8.17
- Average True Range (ATR)
- YORW 0.65
- BCYC 0.42
- MACD
- YORW -0.04
- BCYC 0.10
- Stochastic Oscillator
- YORW 39.05
- BCYC 88.28
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.